Literature DB >> 4418165

Inhibition of thyrotropin and prolactin secretions in primary hypothyroidism by 2-Br-alpha-ergocryptine.

K Miyal, T Onishi, M Hosokawa, K Ishibashi, Y Kumahara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4418165     DOI： 10.1210/jcem-39-2-391

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  8 in total

Review 1.  Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.

Authors:  M F Scanlon; M Pourmand; A M McGregor; M D Rodriguez-Arnao; K Hall; A Gomez-Pan; R Hall
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

Review 2.  Pharmacology of bromocriptine in health and disease.

Authors:  A E Mehta; G Tolis
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

3.  Failure of oral bromocriptine to affect hypergastrinemia in two patients with the Zollinger-Ellison syndrome.

Authors:  D F Child; I Laing; P C Ganguli
Journal:  J Endocrinol Invest       Date:  1978-10       Impact factor: 4.256

4.  Inhibition of thyrotropin and prolactin secretion by dopamine in man.

Authors:  F Massara; F Camanni; V Vergano; L Belforte; G M Molinatti
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

5.  Abnormal thyroid stimulating hormone following pituitary surgery.

Authors:  G K Worth; R W Retallack; D H Gutteridge
Journal:  J Endocrinol Invest       Date:  1981 Apr-Jun       Impact factor: 4.256

6.  The physiological role of thyrotropin-releasing hormone in the regulation of thyroid-stimulating hormone and prolactin secretion in the rat.

Authors:  A R Harris; D Christianson; M S Smith; S L Fang; L E Braverman; A G Vagenakis
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

7.  Nomifensine decreases the thyroid-stimulating-hormone response to thyrotropin-releasing-hormone in normal subjects.

Authors:  M Giusti; G Mazzocchi; D Mignone; W Tarditi; G Giordano
Journal:  J Endocrinol Invest       Date:  1983-04       Impact factor: 4.256

Review 8.  The endocrine profile of bromocriptine: its application in endocrine diseases.

Authors:  I Lancranjan
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.